Results Results After 14 days, all samples retained greater than 98% of the initial adenosine concentration, with no evidence of adsorption, visible precipitation, or considerable change in pH, suggesting minimal to no loss of product due to degradation or adsorption.
Conclusion Conclusion Adenosine 50-, 100-, and 220-μg/mL solutions in 50-mL PVC infusion bags containing 0.9% sodium chloride injection or 5% dextrose injection stored at room temperature and refrigerated conditions were stable for at least 14 days.
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This article is available at Fisher Digital Publications: https://fisherpub.sjfc.edu/doctoral_ext_pub/28 Background Adenosine is an endogenous nucleoside present in all cells of the body. Clinically, it is used to convert paroxysmal supraventricular tachycardia to sinus rhythm. This is accomplished by the slowing of conduction time through the A-V node and by interrupting the reentry pathways through the A-V node. 1 In recent years, there has been interest in the use of adenosine to restore hepatic artery flow (HAF) postoperative liver transplantation. Currently, animal data has shown that restoring the hepatic artery buffer response results in improved survival. 2 In this study, 9 female pigs received continuous infusions of adenosine at 0.7 µg/kg/minute until the HAF was greater than 250 ml/minute.
Currently, an ongoing pilot study aims to demonstrate that adenosine infused into the hepatic artery of adult liver transplant recipients will produce an increase in HAF. Low doses of adenosine ranging from 0.7-5.0 mcg/kg/minute are infused via a 16G central venous catheter line into a branch of the hepatic artery (normally ligated during liver transplant). To maintain patency of the artery with sufficient flow from the catheter and simultaneously achieve low doses of adenosine, low concentrations are necessary for infusion into the catheter for up to 48 hours post-transplantation. There is little data on the stability of diluted solutions of adenosine. One study reports adenosine diluted to 750 µg/ml with 0.9% sodium chloride injection, 5% dextrose injection, lactated Ringer's injection, or 5% dextrose and lactated Ringer's injection as being stable at 25, 5, and -15°C for at least 14 days. 3 Because no information is available on the stability of adenosine solutions at lower concentrations, this study was designed to determine the stability of adenosine solutions of 50, 100, and 220 µg/ml prepared in 50 ml polyvinyl chloride (PVC) IV bags of 9% sodium chloride injection and 5% dextrose injection at room temperature (23-25°C) and refrigerated (2-8°C) for 14 days.
Methods

RP-HPLC
A stability indicating reverse phase-high performance liquid chromatography (RP-HPLC) method using a Shimadzu model LC-2010A HT HPLC instrument a with a C18 3.5 µm, 4.6 x 150 mm column b maintained at 40 °C was employed in this stability study. The Shimadzu instrument contained a degasser, autosampler, and UV detector within. The UV detector was set at 259 nm, the wavelength at which adenosine is absorbed absorbs UV light. 3 Shimadzu LC Solution software was used for data collection and processing. The mobile phase consisted of methanol c and distilled water (5:95 v/v) with 0.1% trifluoroacetic acid d . Injections of 1 µl samples of adenosine eluted at a rate of 0.5 ml/min with an average retention time of 6 minutes.
Assay Validation
In accordance with guidelines provided by the American Journal of Hospital Pharmacy, a stability-indicating assay was used. 4 A forced degradation study was conducted to show the ability of the assay to separate the degradation products from the parent drug. A stock solution was prepared by placing 10 mg of adenosine powder e in a 10 ml volumetric, with distilled water making up the remaining balance, and then stirred for 45 minutes to ensure complete dissolution.
From the stock solution, four 100 µg/ml solutions, 10 ml each were prepared with distilled water as the diluents. Using a previously reported procedure, the samples were prepared as follows 3 :
Sample 1 was adjusted to pH 2 with 1M hydrochloric acid and incubated at 60 °C for 95 hours.
Sample 2 was adjusted to pH 12 with 1M sodium hydroxide and incubated at 60 °C for 95 hours.
Sample 3 was spiked with 3% hydrogen peroxide (final concentration) and incubated at 60 °C for 95 hours. Sample 4 was spiked with 3% hydrogen peroxide and placed in a window sill in direct sunlight for 95 hours. RP-HPLC analysis was performed at time zero and at 95 hours for each sample.
Standards of adenosine at 10, 50, 100, 300, and 500 µg/ml with distilled water as the diluents were prepared from a stock solution of 25 mg/ml. These standards were assayed by RP-HPLC in triplicate on three consecutive days. Table 1 shows the intra-day variability of the assay. The inter-day results were calculated from the intra-day data and are shown in Table 2 .
At time zero, another set of standards were prepared using the same concentrations and method as the standards above. Using linear regression, a calibration curve was constructed of the peak area of adenosine against adenosine concentration. The curve was linear over the range of concentrations (r 2 = 0.999). See Table 3 for the complete data.
Stability Study
Before preparing the samples, the contents of three 50 ml bags of 9% sodium chloride injection f of the same lot and three 50 ml bags of 5% dextrose injection g of the same lot were emptied and measured to determine the overfill volume. The average overfill volume for each of the diluents was 7 ml. For each concentration being studied (50, 100, and 220 µg/ml), the volume of the adenosine solution to be injected was withdrawn from each bag along with the 7 ml overfill. Adenosine h 50, 100, and 220 µg/ml samples were prepared in triplicate in either 9% sodium chloride injection or 5% dextrose injection and stored at room temperature (23-25 °C) or refrigerated (2-8 °C) for a total of 36 samples. All preparations were done using aseptic techniques in a class II biological safety cabinet i .
Visual inspection and RP-HPLC was performed at time zero, 24 hours, 48 hours, 7 days, and 14 days. When the bags were removed from their controlled-temperature environments, a sample was collected and inspected against a light background to inspect for clarity, color and the presence of crystalline particulate matter. At time zero, 48 hours, 7 days, and 14 days, 2 ml of each sample was withdrawn for pH measurements. On each day that pH was measured, the pH meter j was calibrated with pH 4 k and pH 7 l buffer solutions yielding a slope ≥ 97% at 25.0 °C.
The average of the pH values of each triplicate ± the standard deviation was calculated. For RP-HPLC analysis, 1 ml was withdrawn from each sample. The equation y = 6450.1x -21984 from the calibration curve was used to calculate the initial concentration as well as the percent of the initial concentration remaining using the average of the triplicate ± the standard deviation.
Stability for this study was defined as ≥ 90% of the initial concentration remaining.
Results and Discussion
At the start of the study, each sample was visually inspected with no precipitation found.
Time zero concentrations and pH measurements were also recorded. At the end of the 14 day study, all samples remained clear and free of precipitation. All samples retained greater than 98% of the initial concentration at all time points, suggesting minimal if any loss of product due to degradation or adsorption (Table 4 ).
According to the manufacturers, the pH of adenosine 3 mg/ml solution h is 5.5 -7.5, 0.9% sodium chloride injection f is 4.5 -7.0, and 5% dextrose injection g is 3.2 -6.5. Due to the small sample volume (2 ml) used and the wide range of values, the pH measurements were inconsistent and variable (Table 5 ). However, the pH of the samples with 0.9% sodium chloride were consistently higher (pH 6.24 -8.07) than the pH of the samples with 5% dextrose (pH 5.80 -6.84). Another set of samples were prepared in the same manner to verify the accuracy of the time zero pH measurements. These samples also showed variability but remained in the same pH range.
Conclusion
Adenosine 50, 100, and 220 µg/ml solutions in 50 ml IV bags of 0.9% sodium chloride injection and 5% dextrose injection stored at room temperature and refrigerated conditions were stable for at least 14 days. 
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